1. Rituximab as a Therapeutic Strategy in Hemophagocytic Lymphohistiocytosis: Efficacy, Outcomes, and Survival—Insights From a Systematic Review
   Zaheer Qureshi et al, 2024, American Journal of Clinical Oncology CrossRef